| Literature DB >> 29490516 |
Cosme Alvarado-Esquivel1, Luis Francisco Sánchez-Anguiano2, Jesús Hernández-Tinoco2, Agar Ramos-Nevarez3, Sergio Estrada-Martínez2, Sandra Margarita Cerrillo-Soto3, Gonzalo Elías Medina-Heredia4, Carlos Alberto Guido-Arreola3, Araceli Alejandra Soto-Quintero4, Isabel Beristain-Garcia4.
Abstract
Objectives This study was performed to determine the association between seropositivity to Toxoplasma gondii and a history of blood transfusion. Methods Patients who had undergone blood transfusion (n = 410) and age- and sex-matched controls who had not undergone blood transfusion (n = 1230) were examined for anti- T. gondii IgG and IgM antibodies using enzyme-linked immunoassays. Results Anti- T. gondii IgG antibodies were detected in 57 (13.9%) patients and in 129 (10.5%) controls with a borderline difference [odds ratio (OR) = 1.37, 95% confidence interval (CI) = 0.98-1.92]. High anti- T. gondii IgG antibody levels (>150 IU/mL) were found in 27 (47.4%) of the 57 anti- T. gondii IgG-positive patients and in 37 (28.7%) of the 129 anti- T. gondii IgG positive controls with a significant difference (OR = 2.23, 95% CI = 1.17-4.26). Anti- T. gondii IgM antibodies were found in 13 (22.8%) of the 57 seropositive patients and in 37 (28.7%) of the 129 seropositive controls, but the difference was not significant (OR = 0.73, 95% CI = 0.35-1.52). Seroprevalence was significantly higher in patients aged >50 years than in controls of the same age and in female patients than in female controls. Conclusions These findings indicate that a history of blood transfusion is a risk factor for T. gondii infection.Entities:
Keywords: Mexico; Seroprevalence; Toxoplasma gondii; blood transfusion; case-control study; risk factor
Mesh:
Year: 2018 PMID: 29490516 PMCID: PMC6091851 DOI: 10.1177/0300060518757928
Source DB: PubMed Journal: J Int Med Res ISSN: 0300-0605 Impact factor: 1.671
Comparison of seroprevalence of Toxoplasma gondii infection between cases and controls according to age and sex.
Cases | Controls | ||||||
|---|---|---|---|---|---|---|---|
Subjects tested | Seroprevalence of | Subjects tested | Seroprevalence of | ||||
| Characteristics | n | n | % | n | n | % | |
| Age, years | |||||||
| ≤30 | 72 | 9 | 12.5 | 210 | 22 | 10.5 | 0.63 |
| 31–50 | 236 | 28 | 11.9 | 716 | 79 | 11.0 | 0.72 |
| >50 | 102 | 20 | 19.6 | 304 | 28 | 9.0 | 0.005 |
| Sex | |||||||
| Male | 57 | 7 | 12.3 | 171 | 29 | 17.0 | 0.40 |
| Female | 353 | 50 | 14.2 | 1059 | 100 | 9.4 | 0.01 |